Weight loss and diabetes may just be the beginning for drugs like Ozempic, Wegovy, Mounjaro, and Zepbound as reports increasingly suggest they may have far-reaching benefits for treating conditions as diverse as heart and liver disease, Parkinson’s, anxiety, and addiction, sparking research among firms competing in pharma’s latest gold rush.
